drugset / Trial / NCT03651752
DPCP for the Treatment of Alopecia Areata
NaSingle-groupOpen-labelTreatment
Summary
This is an open labeled study to determine the response and characteristics, safety and efficacy, of the proprietary DPCP ointment composition as a topical immunotherapeutic agent for the treatment of extensive alopecia areata.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphencyprone | Small molecule | 0.75 g | Topical |
| Subject | Diphencyprone | Small molecule | 1 g | Topical |